Screening for Preeclampsia

Welcome to this educational course on screening for preeclampsia in the first, second and third trimesters of pregnancy.

The course will cover:

• Background to PE, including definition, prevalence, implications, and pathogenesis
• Prevention of PE, by such measures as bed rest, dietary manipulations and use of low dose aspirin
• Prediction of PE by a combination of maternal characteristics and history and biochemical and biophysical markers
• Performance of screening for PE in the first, second and third trimesters of pregnancy
• Stratification of pregnancy management

Screening at 11-13 weeks identifies a high-risk group where administration of aspirin can substantially reduce the incidence of preterm preeclampsia.

Screening during the second and third trimesters identifies a high-risk group where intensive monitoring could lead to early diagnosis of preeclampsia and reduction in the adverse perinatal events associated with the disease.

The course lasts for about 1 hour, but it does not need to be completed in a single session.

Upon completing the course, you will obtain a certificate of attendance.

The course is mandatory as part of the FMF Certification in Screening for Preeclampsia.